The percentage of patients with chronic kidney disease stage 5 and an LDL greater than or equal to 130 mg/dl that have a current refill for a lipid lowering agent.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting
-
1.14 Numerator
Patients with a current refill for a lipid lowering agent.
-
1.15 Denominator
All patients, ages 18 and older, diagnosed with chronic kidney disease stage 5, dialysis, or kidney transplant, and an LDL level above 130 mg/dL.
-
Exclusions
Specific Exclusions:
None
General Exclusions:
• Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
• Patients who have been in a skilled nursing facility in the last 3 months
• Patient or provider feedback indicating allergy or intolerance to the drug in the past
• Patient or provider feedback indicating that there is a contraindication to adding the drug
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Renal Consensus Standards Endorsement Maintenance 2011Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization Copyright
This information, including any attachments hereto, is the sole, exclusive, proprietary and confidential property of ActiveHealth Management, Inc., and is for the exclusive use of The National Quality Forum. Any use, copying, disclosure, dissemination or distribution by anyone other than the National Quality Forum is strictly prohibited.
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-